1/19
08:12 am
jbio
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue [Yahoo! Finance]
Medium
Report
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue [Yahoo! Finance]
1/8
06:15 am
jbio
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
1/7
07:18 am
jbio
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Low
Report
Jade Biosciences (NASDAQ:JBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
1/6
08:27 am
jbio
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
Low
Report
Institutional investors in Jade Biosciences, Inc. (NASDAQ:JBIO) must be dismayed after prices dropped by 16% last week [Yahoo! Finance]
1/5
07:19 am
jbio
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:00 am
jbio
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
12/16
04:38 pm
jbio
Jade Biosciences (NASDAQ:JBIO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Jade Biosciences (NASDAQ:JBIO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/15
07:05 am
jbio
Jade Biosciences Announces $45 Million Private Placement [Yahoo! Finance]
Low
Report
Jade Biosciences Announces $45 Million Private Placement [Yahoo! Finance]
12/15
07:00 am
jbio
Jade Biosciences Announces $45 Million Private Placement
Low
Report
Jade Biosciences Announces $45 Million Private Placement
12/10
02:27 pm
jbio
Jade Biosciences (JBIO): Analyst Lauds Entry into Market [Yahoo! Finance]
Low
Report
Jade Biosciences (JBIO): Analyst Lauds Entry into Market [Yahoo! Finance]
11/18
02:00 pm
jbio
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock [Yahoo! Finance]
Medium
Report
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock [Yahoo! Finance]
11/18
09:14 am
jbio
Jade Biosciences (NASDAQ:JBIO) had its price target raised by analysts at Guggenheim from $14.00 to $17.00. They now have a "buy" rating on the stock.
Medium
Report
Jade Biosciences (NASDAQ:JBIO) had its price target raised by analysts at Guggenheim from $14.00 to $17.00. They now have a "buy" rating on the stock.
11/15
01:42 am
jbio
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at
Wall Street Z
High
Report
Jade Biosciences (NASDAQ:JBIO) was upgraded by analysts at
Wall Street Z